Literature DB >> 3121214

An international collaborative study on standardization of apolipoproteins A-I and B. Part I. Evaluation of a lyophilized candidate reference and calibration material.

S J Smith1, G R Cooper, L O Henderson, W H Hannon.   

Abstract

We evaluated a lyophilized serum preparation for use as a candidate Reference Material for apolipoproteins (apo) A-I and B. An international collaborative study was conducted with 28 participating laboratories, selected on the basis of participation and demonstrated expertise in a 1983 survey of apolipoproteins A-I and B. The analytical suitability of the material was established by confirming linearity of its dose-response curves over a desired concentration range and demonstrating that its response curves paralleled those for fresh sera. Differences in dilution-adjusted mass units ascribable to the five analytical methods used by the various laboratories constituted only 1% of the total variation for apo A-I, but 32% for apo B. The dominant source of error, however, for both apo A-I and B was the variability among laboratories, rather than variability among methods and antisera. The assigned consensus mass-concentration units based on study data are 1.124 g/L for apo A-I, 0.589 g/L for apo B. For these estimates the coefficients of variation were 13% and 27%, respectively. These findings on the proposed Reference Material meet the requirements suggested by the World Health Organization's Expert Committee on Biological Standards for a candidate WHO Reference Preparation.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3121214

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  14 in total

1.  Three-fold effect of lovastatin treatment on low density lipoprotein metabolism in subjects with hyperlipidemia: increase in receptor activity, decrease in apoB production, and decrease in particle affinity for the receptor. Results from a novel triple-tracer approach.

Authors:  L Berglund; J L Witztum; N F Galeano; A S Khouw; H N Ginsberg; R Ramakrishnan
Journal:  J Lipid Res       Date:  1998-04       Impact factor: 5.922

2.  Candidate-gene studies of the atherogenic lipoprotein phenotype: a sib-pair linkage analysis of DZ women twins.

Authors:  M A Austin; P J Talmud; L A Luong; L Haddad; I N Day; B Newman; K L Edwards; R M Krauss; S E Humphries
Journal:  Am J Hum Genet       Date:  1998-02       Impact factor: 11.025

3.  Plasma triglyceride concentrations are rapidly reduced following individual bouts of endurance exercise in women.

Authors:  Gregory C Henderson; Ronald M Krauss; Jill A Fattor; Nastaran Faghihnia; Mona Luke-Zeitoun; George A Brooks
Journal:  Eur J Appl Physiol       Date:  2010-03-09       Impact factor: 3.078

4.  Increased plasma and renal clearance of an exchangeable pool of apolipoprotein A-I in subjects with low levels of high density lipoprotein cholesterol.

Authors:  B S Horowitz; I J Goldberg; J Merab; T M Vanni; R Ramakrishnan; H N Ginsberg
Journal:  J Clin Invest       Date:  1993-04       Impact factor: 14.808

5.  Plasma lipid, lipoprotein and apolipoprotein profiles in Nigerian university athletes and non-athletes.

Authors:  O O Oyelola; M A Rufai
Journal:  Br J Sports Med       Date:  1993-12       Impact factor: 13.800

6.  Comparison of the DASH (Dietary Approaches to Stop Hypertension) diet and a higher-fat DASH diet on blood pressure and lipids and lipoproteins: a randomized controlled trial.

Authors:  Sally Chiu; Nathalie Bergeron; Paul T Williams; George A Bray; Barbara Sutherland; Ronald M Krauss
Journal:  Am J Clin Nutr       Date:  2015-12-30       Impact factor: 7.045

7.  Diets high in protein or saturated fat do not affect insulin sensitivity or plasma concentrations of lipids and lipoproteins in overweight and obese adults.

Authors:  Sally Chiu; Paul T Williams; Taylor Dawson; Richard N Bergman; Darko Stefanovski; Steven M Watkins; Ronald M Krauss
Journal:  J Nutr       Date:  2014-09-03       Impact factor: 4.798

8.  Metabolism by human endothelial cells of very low density lipoprotein subfractions isolated from type 1 (insulin-dependent) diabetic patients.

Authors:  R L Klein; M F Lopes-Virella
Journal:  Diabetologia       Date:  1993-03       Impact factor: 10.122

9.  Plasma lipids, lipoproteins, and apolipoproteins in Nigerian diabetes mellitus, essential hypertension, and hypertensive-diabetic patients.

Authors:  O O Oyelola; A A Ajayi; R O Babalola; E A Stein
Journal:  J Natl Med Assoc       Date:  1995-02       Impact factor: 1.798

10.  A dose-response study of the effects of dietary cholesterol on fasting and postprandial lipid and lipoprotein metabolism in healthy young men.

Authors:  H N Ginsberg; W Karmally; M Siddiqui; S Holleran; A R Tall; S C Rumsey; R J Deckelbaum; W S Blaner; R Ramakrishnan
Journal:  Arterioscler Thromb       Date:  1994-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.